Article 13 Nov 2024 Life Sciences M&A Trends For 2023 And 2024 (Through End Of Q3) In Greater China China Healthcare
Article 12 Nov 2024 FDA Accepts BLA For Shanghai Henlius Biotech's And Organon's HLX14, A Denosumab Biosimilar China Healthcare
Article 14 Oct 2024 PTAB Institutes Eight More IPRs Filed By Merck On Johns Hopkins Pembrolizumab Patents United States IP
Article 07 Oct 2024 Express Scripts Sues FTC Over Report On Pharmacy Benefit Management Industry United States Healthcare
Article 19 Mar 2024 Major Life Sciences Licensing Deal Trends In China In 2023 United States Healthcare
Article 04 Dec 2023 Unlocking AI's Power To Multiply Manufacturing Productivity United States Technology
Article 30 Nov 2023 Regeneron Sues Samsung Bioepis For Proposed Biosimilar Of EYLEA In West Virginia District Court United States Healthcare
Article 22 Nov 2023 UK Authorizes World-First Gene Therapy From Vertex And CRISPR Therapeutics For Blood Disorders United Kingdom Healthcare